Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Radiotherapy × 90 days × Clear all

Phase

Phase 2 102 Phase 3 56 Phase 1 37 Phase NA 25 Phase 1/2 18 Phase 2/3 8 Phase EARLY_PHASE1 4 Phase 4 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 1

Interventions

Letrozole 6 Specimen Handling 5 Rituximab 5 Dexamethasone 5 Tobacco Use Cessation Devices 4 Tamoxifen 4 Prednisone 4 Cisplatin 4 Carboplatin 4 Bevacizumab 4 Anastrozole 4 ribociclib 3 pirtobrutinib 3 pembrolizumab 3 exemestane 3 atezolizumab 3 Vincristine 3 Trastuzumab 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 Injections 3 Everolimus 3 Doxorubicin 3 trametinib 2 relatlimab 2 obinutuzumab 2 nilotinib 2 gadolinium ethoxybenzyl DTPA 2 enzalutamide 2 enfortumab vedotin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07483060 2026-03-19

NG-ST

Vastra Gotaland Region

Phase 4 Not yet recruiting

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡